Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03779282 · ClinicalTrials.gov registry record
KETODEX for Emergence Delirium in Children Undergoing Outpatient Strabismus Surgery
A clinical trial, sponsored by Ochsner Health System.
- Completed
- Registry status
- 90
- Enrollment target
NCT03779282: Completed study, sponsored by Ochsner Health System.
NCT03779282 is a clinical trial that has completed, run by Ochsner Health System. The registered enrollment target is 90 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03779282 has completed, sponsored by Ochsner Health System.
- COMPLETED
- Registry status
- 90 participants
- Enrollment target
Study Summary
Strabismus surgery for children is a very common procedure, with a high incidence of emergence delerium in the recovery room. A combination of intravenous ketamine/dexmedetomidine, or ketodex, has been previously shown to reduce emergence delerium in children undergoing adenotonsillectomy. Here, we study its application in strabismus surgery.
Primary Outcome
A low total score would indicate less emergence delirium
Interventions
- DRUG Dexmedetomidine
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 90 participants |
| Start Date | 2018-02-15 |
| Est. Completion | 2018-09-15 |
What the finished NCT03779282 record still lists
NCT03779282 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 90 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which Dexmedetomidine is the first listed.
NCT03779282 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03779282 about?
NCT03779282 is a clinical study titled "KETODEX for Emergence Delirium in Children Undergoing Outpatient Strabismus Surgery". Strabismus surgery for children is a very common procedure, with a high incidence of emergence delerium in the recovery room. A combination of intravenous ketamine/dexmedetomidine, or ketodex, has been previously shown to reduce emergence delerium in children undergoing adenotonsillectomy. Here, we ...
What is the current status of trial NCT03779282?
This trial is currently completed. The enrollment target is 90 participants. The study started on 2018-02-15. Estimated completion is 2018-09-15.
What interventions are being tested in trial NCT03779282?
The interventions under investigation include: Dexmedetomidine (DRUG).
Who is sponsoring clinical trial NCT03779282?
This trial is sponsored by Ochsner Health System, which has 29 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02521311 · 90 participants · Phase 2
Assessment of Clemastine Fumarate as a Remyelinating Agent in Acute Optic Neuritis (ReCOVER)
- NCT02939573 · 90 participants · Phase 2
A Randomized Multicenter Study for Isolated Skin Vasculitis
- NCT03128879 · 90 participants · Phase 2
Venetoclax With Ibrutinib or Acalabrutinib in Pts. With High-risk CLL
- NCT03184038 · 90 participants · NA
Neurocognition in Patients With Multiple Brain Metastases Treated With Radiosurgery
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI